# Topical Dexamethasone, Ascorbic Acid, and BGP for Enhancing Implant Osseointegration

> **NCT07060859** · NA · COMPLETED · sponsor: **Manar Ziad Foura-Matar** · enrollment: 18 (actual)

## Conditions studied

- Implant Stability and Osseointegration

## Interventions

- **DRUG:** Topical Application of Dexamethasone, Ascorbic Acid, and β-Sodium Glycerophosphate

## Key facts

- **NCT ID:** NCT07060859
- **Lead sponsor:** Manar Ziad Foura-Matar
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-15
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07060859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07060859, "Topical Dexamethasone, Ascorbic Acid, and BGP for Enhancing Implant Osseointegration". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07060859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*